Association of UGT2B7 and ABCB1 genotypes with morphine-induced adverse drug reactions in Japanese patients with cancer
about
The pharmacogenomics of pain management: prospects for personalized medicineABCC3 and OCT1 genotypes influence pharmacokinetics of morphine in children.Toward a systematic approach to opioid rotation.Genetic risk signatures of opioid-induced respiratory depression following pediatric tonsillectomyPharmacogenomic considerations in the opioid management of painMechanistic basis of altered morphine disposition in nonalcoholic steatohepatitis.Quantification of morphine and its major metabolites M3G and M6G in antemortem and postmortem samples.Is ethnicity associated with morphine's side effects in children? Morphine pharmacokinetics, analgesic response, and side effects in children having tonsillectomyAversive and reinforcing opioid effects: a pharmacogenomic twin study.Genetic and Non-genetic Factors Associated With Constipation in Cancer Patients Receiving Opioids.Pharmacogenetics of chronic pain and its treatment.Pathophysiological and neurochemical mechanisms of postoperative nausea and vomitingPain, analgesia and genetics.Morphine metabolism, transport and brain disposition.Opioid genetics: the key to personalized pain control?Pharmacogenomics of opioids and perioperative pain management.Genetic factors associated with pharmacotherapy and background sensitivity to postoperative and chemotherapy-induced nausea and vomiting.Pharmacogenetics of chemotherapy-induced nausea and vomiting.Codeine should not be prescribed for breastfeeding mothers or children under the age of 12.Transporter-Mediated Disposition of Opioids: Implications for Clinical Drug Interactions.The pharmacogenetics of opioid therapy in the management of postpartum pain: a systematic review.Changes in drug transport and metabolism and their clinical implications in non-alcoholic fatty liver disease.Pharmacogenomics and pharmacogenetics for the intensive care unit: a narrative review.Pharmacogenomics and Patient Treatment Parameters to Opioid Treatment in Chronic Pain: A Focus on Morphine, Oxycodone, Tramadol, and Fentanyl.Influence of UGT2B7, OPRM1 and ABCB1 gene polymorphisms on postoperative morphine consumption.Acute kidney injury in a preterm infant homozygous for the C3435T polymorphism in the ABCB1 gene given oral morphine.Relationship Between ABCB1 Polymorphisms and Cold Pain Sensitivity Among Healthy Opioid-naive Malay Males.Pharmacokinetics of Morphine in Rats with Adjuvant-induced Arthritis.The opioid epidemic: a central role for the blood brain barrier in opioid analgesia and abuse.Effect of UGT2B7 -900G>A (-842G>A; rs7438135) on morphine glucuronidation in preterm newborns: results from a pilot cohort.Pharmacogenetics of opiates in clinical practice: the visible tip of the iceberg.Prediction of codeine toxicity in infants and their mothers using a novel combination of maternal genetic markers.Preoperative Genetic Testing and Personalized Medicine: Changing the Care Paradigm.Why is there no morphine concentration-response curve for acute pain?
P2860
Q26765266-B49AA699-7DA7-4887-9134-7F6BD198AEFEQ34308014-7A6DAA4D-335C-4D58-BA04-258CD647BB63Q34394425-A7854AA0-979E-4108-B387-BB45711AE4ABQ34872670-01D71EB4-88C7-4EAB-8CA1-5B1D371A90FFQ34971560-35E37579-846D-471D-8145-344D064123F1Q35156418-9C3C6599-F27A-4E81-A300-37EBA2A909B0Q35264107-C1D89710-C757-4CA5-9DCC-EFE18DBCA56CQ36004048-2A277977-B4DF-4852-847E-CD7561B7C2A3Q36191409-09DC9BD0-35B7-4B1D-A063-BD6CB4FAD0A7Q36751995-DE702CBB-7A69-4480-82E4-FA1163D32BDDQ36900075-A0035800-21B3-4273-9030-6A922DC90983Q37559641-C24F8762-1A34-4B9D-AF10-F08D03BB90B8Q37944353-38E94D52-5211-4476-B6B6-A85774C4CFD8Q37970914-3C8A7BB9-BD9E-4045-B19C-C5C3A4069FA5Q38025200-B8F32306-82B1-4E0A-A330-CFA82AF8357FQ38061498-642476D1-51CA-4EAC-A06E-5E973F8B45C5Q38209001-17F9C2A6-86AC-4D71-8031-D175669884B3Q38330216-8D095E57-5905-43CA-A292-BC6E90939423Q38391114-B6290A33-33A8-4ECF-8550-62B6E10043B9Q38478413-86BC34BD-E3E0-43E4-83C5-DF84F5E71591Q38664725-0913E143-F9BE-4361-862B-40DF7BCA8C91Q38737633-DD1EE369-E0AF-4A65-B009-5A12C7EEA9A9Q38983589-7916384E-24ED-4B5B-AC6E-C7C708362F02Q39198915-41F78CE9-275D-411C-AA7D-D258DDDD0C14Q39208984-B8B3C77F-13F4-437F-833A-E3CA97988ADFQ40684580-842CEB57-933F-46D5-875F-A766EC38CDD5Q44342118-F062BA24-B67F-437E-8465-745E5D6E034FQ44904802-65E4F0C4-3328-4A4A-832A-79AA8D1376F2Q47149253-1108619E-6C9F-4F97-8982-CDDE72CD98FAQ47796637-BDC93FE8-0990-4B48-BC72-FD80CDC16449Q48490118-72C880D4-899B-4CCE-914C-80A3F27D3E51Q48717168-9CAB0908-AB5F-49C1-8F8C-5AA2EE98D068Q50078978-65F67A93-69B2-4851-85A7-473D44F835A3Q51119182-08EB7678-47BC-423B-A244-78F70DC52FE4
P2860
Association of UGT2B7 and ABCB1 genotypes with morphine-induced adverse drug reactions in Japanese patients with cancer
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Association of UGT2B7 and ABCB ...... Japanese patients with cancer
@ast
Association of UGT2B7 and ABCB ...... Japanese patients with cancer
@en
Association of UGT2B7 and ABCB ...... Japanese patients with cancer
@nl
type
label
Association of UGT2B7 and ABCB ...... Japanese patients with cancer
@ast
Association of UGT2B7 and ABCB ...... Japanese patients with cancer
@en
Association of UGT2B7 and ABCB ...... Japanese patients with cancer
@nl
prefLabel
Association of UGT2B7 and ABCB ...... Japanese patients with cancer
@ast
Association of UGT2B7 and ABCB ...... Japanese patients with cancer
@en
Association of UGT2B7 and ABCB ...... Japanese patients with cancer
@nl
P2093
P1476
Association of UGT2B7 and ABCB ...... Japanese patients with cancer
@en
P2093
Fumio Nagashima
Hiroyasu Iwasa
Hiroyasu Ogata
Hisashi Endo
Kaori Kawara
Keiji Kodama
Ken-ichi Fujita
Mari Shiomi
Masaru Narabayashi
Takashi Hirose
P2888
P304
P356
10.1007/S00280-009-1029-2
P407
P577
2010-01-01T00:00:00Z
P5875
P6179
1050175972